Hinge Health Inc. (NYSE:HNGE - Get Free Report) has been assigned a consensus rating of "Buy" from the fourteen research firms that are presently covering the company, Marketbeat.com reports. Fourteen research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $49.36.
A number of equities analysts recently weighed in on HNGE shares. Raymond James Financial started coverage on shares of Hinge Health in a report on Monday, June 16th. They issued an "outperform" rating and a $45.00 price objective for the company. Truist Financial started coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $48.00 target price for the company. Canaccord Genuity Group started coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $52.00 target price for the company. Stifel Nicolaus started coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $48.00 target price for the company. Finally, Needham & Company LLC started coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $47.00 target price for the company.
Get Our Latest Stock Analysis on Hinge Health
Hinge Health Stock Performance
HNGE traded up $0.55 on Friday, hitting $48.19. The company had a trading volume of 829,051 shares, compared to its average volume of 1,042,935. Hinge Health has a 52-week low of $33.42 and a 52-week high of $52.16.
Hinge Health Company Profile
(
Get Free ReportOur vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Recommended Stories
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
